Brinda Balakrishnan
Directeur/Membre du Conseil chez AURINIA PHARMACEUTICALS INC.
Fortune : 100 056 $ au 30/06/2024
Profil
Brinda Balakrishnan had a career history that included founding Vision Medicines, Inc. in 2013, where she held the title of VP-Corporate Strategy & Product Development from 2013 to 2016.
Currently, she is an Independent Director at Aurinia Pharmaceuticals, Inc. since 2021 and the Chief Business Development Officer & SVP at BioMarin Pharmaceutical, Inc. since 2016.
Dr. Balakrishnan has an educational background that includes undergraduate and doctorate degrees from the Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2024 | 17 523 ( 0,01% ) | 100 056 $ | 30/06/2024 |
Postes actifs de Brinda Balakrishnan
| Sociétés | Poste | Début |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2016 |
| AURINIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 14/06/2021 |
Anciens postes connus de Brinda Balakrishnan
| Sociétés | Poste | Fin |
|---|---|---|
Vision Medicines, Inc.
 Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Fondateur | 01/01/2016 |
Formation de Brinda Balakrishnan
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
